Persevere Therapeutics

Berwyn, United States

Persevere Therapeutics is a clinical-stage pharmaceutical company that develops novel therapeutics for effective cancer treatments.

$1.6M raised

Mar 2026

Seed

Oncology Pharmaceutical Therapeutics

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Persevere Therapeutics

How much funding has Persevere Therapeutics raised?

Persevere Therapeutics has raised $1.6M in total funding. The most recent round was Seed. The last funding was announced in March 2026.

Where is Persevere Therapeutics headquartered?

Persevere Therapeutics is headquartered in Berwyn, United States.

What does Persevere Therapeutics do?

Persevere Therapeutics is a clinical-stage pharmaceutical company that develops novel therapeutics for effective cancer treatments.

What stage is Persevere Therapeutics at?

Persevere Therapeutics is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 3, 2026.

MLA

"Persevere Therapeutics — Funding & Investors." VCBacked, March 3, 2026, https://www.vcbacked.co/company/persevere-therapeutics. Accessed July 2, 2026.

APA

VCBacked. (2026). Persevere Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/persevere-therapeutics

Wikipedia (cite web)

{{cite web |title=Persevere Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/persevere-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 3, 2026.